Acyclovir
Product Images NDC 75834-123

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 75834-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Acyclovir 01)

Chemical structure diagram of Acyclovir, depicting its molecular arrangement with atoms and bonds, including characteristic rings and side chains.*

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Acyclovir Tablets, USP 400 mg label from Nivagen Pharmaceuticals, Inc. The label indicates packaging of 100 tablets with the NDC 75834-122-01. It includes storage instructions, manufacturer information including Cadila Pharmaceuticals Ltd., and contact details. The label also displays two barcodes and an issue date of 08/2016.*

FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

Acyclovir Tablets, USP 800 mg label displaying a package of 100 tablets. The label includes storage instructions (15° to 25°C, protect from light and moisture), manufacturer information for Nivagen Pharmaceuticals, Inc. in Sacramento, CA, and manufacturer Cadila Pharmaceuticals Ltd. in Ahmedabad, India. The label also shows the NDC number 75834-123-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.